BlackRock Investment Management, LLC - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 153 filers reported holding JUNO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.17 and the average weighting 0.9%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$597,000
-22.4%
31,662
+23.5%
0.00%0.0%
Q3 2016$769,000
-21.0%
25,635
+1.3%
0.00%0.0%
Q2 2016$973,000
+446.6%
25,315
+440.3%
0.00%
Q1 2016$178,000
-33.3%
4,685
-22.9%
0.00%
Q4 2015$267,000
+11.7%
6,076
+3.3%
0.00%
Q3 2015$239,000
-32.5%
5,883
-11.3%
0.00%
Q2 2015$354,000
+91.4%
6,630
+117.6%
0.00%
Q1 2015$185,000
-59.3%
3,047
-65.0%
0.00%
-100.0%
Q4 2014$454,0008,7000.00%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Crestline Management, LP 25,948,799$1,055,857,000100.00%
Omega Fund Management, LLC 1,329,512$54,098,00030.46%
SOUND ENERGY PARTNERS, INC. 25,800$1,050,0002.12%
Graticule Asia Macro Advisors LLC 435,205$17,708,0002.06%
BB BIOTECH AG 1,305,000$53,100,0001.68%
Kazazian Asset Management, LLC 13,376$544,0000.69%
Rock Springs Capital Management LP 197,001$8,016,0000.65%
TURNER INVESTMENTS LLC 69,680$2,835,0000.57%
MIZUHO SECURITIES USA LLC 49,600$2,018,0000.52%
Private Capital Advisors, Inc. 27,900$1,135,0000.48%
View complete list of JUNO THERAPEUTICS INC shareholders